Assessing combined anti-platelet therapy in suspected acute myocardial infarction Aspirin
has been shown to be effective in the emergency treatment of acute myocardial infarction. It …

Background Despite improvements in the emergency treatment of myocardial infarction (MI),
early mortality and morbidity remain high. The antiplatelet agent clopidogrel adds to the …

Background—We studied the benefits and risks of adding clopidogrel to different doses of
aspirin in the treatment of patients with acute coronary syndrome (ACS). Methods and …

OBJECTIVES We sought to compare the inhibitory effects of the combination of two doses of
aspirin plus clopidogrel with either drug alone on platelet aggregation and activation …

Antiplatelet agents are central to the treatment and prevention of cardiovascular disease.
Although aspirin is the most widely used agent, randomized trials have assessed whether …

A randomized, double‐blind multicenter trial—the Clopidogrel and Aspirin: Determination of
the Effects on Thrombogenicity (CADET) trial—was carried out to compare the effects of …

Background Despite the use of aspirin, there is still a risk of ischaemic events after
percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to …

Background Clopidogrel and aspirin are widely used for patients with acute coronary
syndromes and those undergoing percutaneous coronary intervention (PCI). However …

A combination of aspirin and clopidogrel decreased cardiovascular events in patients at
high risk of cardiovascular disease and in those with acute coronary syndrome. However …

Platelet adhesion, activation, and aggregation are central to thrombus formation, which
follows atherosclerotic plaque disruption and causes acute coronary syndromes. Aspirin and …